Literature DB >> 15472786

[Quality assurance in rehabilitation: where do we stand today?].

W H Jäckel1, E Farin.   

Abstract

In the sector of medical rehabilitation in Germany, a quality assurance programme has been established over the last decade. What distinguishes this programme in comparison to other sectors of the health care system is its comprehensive approach (including quality of structures, processes and outcomes), the special attention given to patients' needs, its scientific foundation, and its implementation throughout the sector. Participation in this programme is obligatory for all in-patient rehabilitation facilities. For out-patient rehabilitation, a specific programme is currently being developed. The feedback report to the facilities gives them concrete indications of existing strengths and weaknesses and thus offers them a start for developing their quality by means of internal quality management. The article begins with a presentation of the instruments and procedures applied as well as selected results of the previous surveys in the context of external quality assurance. Subsequently, the most important approaches to internal quality management are explained. The article ends with a description of the strengths and weaknesses of the existing quality assurance programmes and proposes steps to be taken for their further development.

Entities:  

Mesh:

Year:  2004        PMID: 15472786     DOI: 10.1055/s-2004-828394

Source DB:  PubMed          Journal:  Rehabilitation (Stuttg)        ISSN: 0034-3536            Impact factor:   1.113


  2 in total

1.  [Quality assurance and guidelines in rehabilitation for musculoskeletal diseases].

Authors:  M Glattacker; E Müller; W H Jäckel
Journal:  Z Rheumatol       Date:  2008-11       Impact factor: 1.372

2.  An instrument for quality assurance in work capacity evaluation: development, evaluation, and inter-rater reliability.

Authors:  André Strahl; Christian Gerlich; Georg W Alpers; Jörg Gehrke; Annette Müller-Garnn; Heiner Vogel
Journal:  BMC Health Serv Res       Date:  2019-08-09       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.